Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill F Blim

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Vitreoretinal Diseases|April 3, 2023
From the EditorsDonald J D'Amico, Timothy G Murray, Jill F Blim
Journal of Vitreoretinal Diseases|April 3, 2023
The Impact of COVID-19 on US and International Retina Specialists, Their Practices, and Their PatientsPaul Hahn, Jill F Blim, Kirk Packo, et al.
JAMA Ophthalmology|November 15, 2019
Economic Value of Anti-Vascular Endothelial Growth Factor Treatment for Patients With Wet Age-Related Macular Degeneration in the United StatesKaren Mulligan, Seth A Seabury, Pravin U Dugel, et al.
JAMA Ophthalmology|August 22, 2018
Evaluation of Clinical Questions and Patient-Important Outcomes Associated With the Treatment of Age-Related Macular DegenerationKristina B Lindsley, Susan Hutfless, Barbara S Hawkins, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Vitreoretinal Diseases|April 3, 2023
From the EditorsDonald J D'Amico, Timothy G Murray, Jill F Blim
Journal of Vitreoretinal Diseases|April 3, 2023
The Impact of COVID-19 on US and International Retina Specialists, Their Practices, and Their PatientsPaul Hahn, Jill F Blim, Kirk Packo, et al.
JAMA Ophthalmology|November 15, 2019
Economic Value of Anti-Vascular Endothelial Growth Factor Treatment for Patients With Wet Age-Related Macular Degeneration in the United StatesKaren Mulligan, Seth A Seabury, Pravin U Dugel, et al.
JAMA Ophthalmology|August 22, 2018
Evaluation of Clinical Questions and Patient-Important Outcomes Associated With the Treatment of Age-Related Macular DegenerationKristina B Lindsley, Susan Hutfless, Barbara S Hawkins, et al.
Pageof 1